Silver Mark S. reported grant involving 22.539 derivative units of Ryerson Holding Corp at $0.00 for $0 on Sep 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
EVP, Chief Legal/Risk Officer
EVP, Chief Legal/Risk Officer
Filed Sep 21, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
22.539Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,989.267Direct
Trade date
Sep 17, 2026Grant
Filed
Sep 21, 2026, 4:50 PM ET4-day reporting delay
Accession
0000899140-26-001076Code A · Transaction 226840
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 17, 2026Grant52.213$0.00$0Trade 226841
Sep 17, 2026Grant75.722$0.00$0Trade 226842
3 transaction rows in this filing. Joint filers share the same rows.

RYZ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RYZ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Sep 28, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027. F4: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027 and March 31, 2028. F5: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2026 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027, March 31, 2028, and March 31, 2029.